Literature DB >> 28921627

Preterm infants with necrotising enterocolitis demonstrate an unbalanced gut microbiota.

Tarek Itani1, Carole Ayoub Moubareck1,2, Imad Melki3, Clotilde Rousseau4,5, Irène Mangin4,6, Marie-José Butel4, Dolla Karam-Sarkis1.   

Abstract

AIM: This Lebanese study tested the hypothesis that differences would exist in the gut microbiota of preterm infants with and without necrotising enterocolitis (NEC), as reported in Western countries.
METHODS: This study compared 11 infants with NEC and 11 controls, all born at 27-35 weeks, in three neonatal intensive care units between January 2013 and March 2015. Faecal samples were collected at key time points, and microbiota was analysed by culture, quantitative PCR (qPCR) and temperature temporal gel electrophoresis (TTGE).
RESULTS: The cultures revealed that all preterm infants were poorly colonised and harboured no more than seven species. Prior to NEC diagnosis, significant differences were observed by qPCR with a higher colonisation by staphylococci (p = 0.034) and lower colonisations by enterococci (p = 0.039) and lactobacilli (p = 0.048) in the NEC group compared to the healthy controls. Throughout the study, virtually all of the infants were colonised by Enterobacteriaceae at high levels. TTGE analysis revealed no particular clusterisation, showing high interindividual variability.
CONCLUSION: The NEC infants were poorly colonised with no more than seven species, and the controls had a more diversified and balanced gut microbiota. Understanding NEC aetiology better could lead to more effective prophylactic interventions and a reduced incidence. ©2017 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Colonisation; Gut microbiota; Necrotising enterocolitis; Preterm infants; Prophylaxis

Mesh:

Year:  2017        PMID: 28921627     DOI: 10.1111/apa.14078

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Preterm infants harbour diverse Klebsiella populations, including atypical species that encode and produce an array of antimicrobial resistance- and virulence-associated factors.

Authors:  Yuhao Chen; Thomas C Brook; Cho Zin Soe; Ian O'Neill; Cristina Alcon-Giner; Onnicha Leelastwattanagul; Sarah Phillips; Shabhonam Caim; Paul Clarke; Lindsay J Hall; Lesley Hoyles
Journal:  Microb Genom       Date:  2020-06

Review 2.  The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.

Authors:  Anthony P Corfield
Journal:  Microorganisms       Date:  2018-08-02

3.  Multidisciplinary evaluation of Clostridium butyricum clonality isolated from preterm neonates with necrotizing enterocolitis in South France between 2009 and 2017.

Authors:  Michel Hosny; Jacques Yaacoub Bou Khalil; Aurelia Caputo; Rita Abou Abdallah; Anthony Levasseur; Philippe Colson; Nadim Cassir; Bernard La Scola
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

Review 4.  Intestinal dysbiosis and necrotizing enterocolitis: assessment for causality using Bradford Hill criteria.

Authors:  Jennifer B Fundora; Pallabi Guha; Darla R Shores; Mohan Pammi; Akhil Maheshwari
Journal:  Pediatr Res       Date:  2019-06-25       Impact factor: 3.756

5.  Yeast fermentate prebiotic improves intestinal barrier integrity during heat stress by modulation of the gut microbiota in rats.

Authors:  H A G Ducray; L Globa; O Pustovyy; E Morrison; V Vodyanoy; I Sorokulova
Journal:  J Appl Microbiol       Date:  2019-07-09       Impact factor: 3.772

Review 6.  Methods for exploring the faecal microbiome of premature infants: a review.

Authors:  Jacob A F Westaway; Roger Huerlimann; Catherine M Miller; Yoga Kandasamy; Robert Norton; Donna Rudd
Journal:  Matern Health Neonatol Perinatol       Date:  2021-03-08

Review 7.  Toll-Like Receptor-Mediated Intestinal Inflammatory Imbalance in the Pathogenesis of Necrotizing Enterocolitis.

Authors:  David J Hackam; Chhinder P Sodhi
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.